- France Cuts Swine Flu Vaccine Order from Novartis (Reuters)
- Pfizer Resumes Melanoma Drug Study (The Day)
- AstraZeneca Makes Deal with Generic Challenger (Business Week)
- Novartis plans complete takeover of Alcon (Business Week)
- Nexium Patent Battle Could Switch To Generic Vs. Generic Fight (Health News Daily)
This is copyright protected information, to receive the full article, please click here to sign up and register.
- Germany cancels part of GSK swine flu vaccine order (The Independent)
- Teva says revenues will double by 2015 (PharmaTimes)
- Troubled Genzyme gets backing of major shareholder (PharmaTimes)
- Strides Acrolab: Drug Licence, Supply Gains Turn It On (The Economic Times)
- Abbott Labs Settles Antitrust Suit (Business Today)
SUBSCRIBE